CANO FRANCIS 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Aug 10, 2022
Insider Transaction Report
Form 4
CANO FRANCIS
Director
Transactions
- Exercise/Conversion
Common Stock
2022-08-08$4.97/sh+15,000$74,550→ 35,834 total - Sale
Common Stock
2022-08-08$17.17/sh−15,000$257,550→ 20,834 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-08−15,000→ 0 totalExercise: $4.97Exp: 2026-05-29→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $17.16 to $17.20; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
- [F2]These options fully-vested on May 30, 2020, upon the one-year anniversary of the grant date.
- [F3]Not applicable.